Dr. Jitendra Singh announces CSIR's indigenously developed Paracetamol
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
MRX-5 is a novel benzoxazole antibiotic developed for the treatment of mycobacteria infections, particularly infections caused by non-tuberculous Mycobacteria
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
In the US, the compassionate use approvals are provided by FDA in the form of individual patient-specific expanded-access IND
Despite NTC014, due to its simplified therapeutic regimen, has been administered at a lower posology than the antibiotic comparator
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Subscribe To Our Newsletter & Stay Updated